Title: Antimalarial screening via large-scale purification of Plasmodium falciparum Ca2+-ATPase 6 and in vitro studies.
Journal: The FEBS journal20131101
Title: Regulation of S100A4 expression via the JAK2-STAT3 pathway in rhomboid-phenotype pulmonary arterial smooth muscle cells exposure to hypoxia.
Journal: The international journal of biochemistry & cell biology20120801
Title: Hypotonic stress upregulates β- and γ-ENaC expression through suppression of ERK by inducing MKP-1.
Journal: American journal of physiology. Renal physiology20120715
Title: Cysteine 81 is critical for the interaction of S100A4 and myosin-IIA.
Journal: Biochemistry20110823
Title: Using small molecules to target protein phosphatases.
Journal: Bioorganic & medicinal chemistry20110401
Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters20101101
Title: The cytotoxic agents NSC-95397, brefeldin A, bortezomib and sanguinarine induce apoptosis in neuroendocrine tumors in vitro.
Journal: Anticancer research20100101
Title: Combination analyses of anti-cancer drugs on human neuroendocrine tumor cell lines.
Journal: Cancer chemotherapy and pharmacology20091201
Title: Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Journal: Nature chemical biology20091001
Title: Novel naphthoquinone and quinolinedione inhibitors of CDC25 phosphatase activity with antiproliferative properties.
Journal: Bioorganic & medicinal chemistry20081001
Title: Nanosecond molecular dynamics simulations of Cdc25B and its complex with a 1,4-naphthoquinone inhibitor: implications for rational inhibitor design.
Journal: Journal of molecular graphics & modelling20080801
Title: A cell-active inhibitor of mitogen-activated protein kinase phosphatases restores paclitaxel-induced apoptosis in dexamethasone-protected cancer cells.
Journal: Molecular cancer therapeutics20080201
Title: Fluorinated NSC as a Cdc25 inhibitor.
Journal: Bioorganic & medicinal chemistry letters20070415
Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.
Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology20060501
Title: The when and wheres of CDC25 phosphatases.
Journal: Current opinion in cell biology20060401
Title: Novel hydroxyl naphthoquinones with potent Cdc25 antagonizing and growth inhibitory properties.
Journal: Molecular cancer therapeutics20050401
Title: Quinone-induced Cdc25A inhibition causes ERK-dependent connexin phosphorylation.
Journal: Biochemical and biophysical research communications20050225
Title: Targeting the neighbor's pool.
Journal: Molecular pharmacology20041001
Title: NAD(P)H:quinone oxidoreductase-1-dependent and -independent cytotoxicity of potent quinone Cdc25 phosphatase inhibitors.
Journal: The Journal of pharmacology and experimental therapeutics20040401
Title: Activation of the Raf-1/MEK/Erk kinase pathway by a novel Cdc25 inhibitor in human prostate cancer cells.
Journal: The Prostate20040101
Title: Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.
Journal: The Journal of biological chemistry20020419
Title: Identification of a potent and selective pharmacophore for Cdc25 dual specificity phosphatase inhibitors.
Journal: Molecular pharmacology20020401
